News | July 03, 2024
LG Chem enters Chinese osteoarthritis treatment market
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Third Phase 3 trial in third type of lymphoma to show improvement in overall survival with an ADCETRIS-containing regimen
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Subscribe To Our Newsletter & Stay Updated
